Win a Grant to the C3 in Orlando, Florida

Participe por una beca para asistir al C3 en Orlando, FloridaFrom June 27th to June 30th, Orlando, Florida will hold the Complex Cardiovascular Catheter Therapeutics (C3 Conference), an event with a steadily growing number of attendees each year.

 

The Conference Organizing Committee grants, through SOLACI, five scholarships for professionals aiming to present their approved work or complex case.

 

Scholarships include the following:

  • Congress registration fee.
  • Three nights lodging for the aforementioned date.
  • Plane tickets through the Congress official travel agency (with a maximum limit of USD 1000).

 

 

How can you submit your work? 

Cases shall be submitted through the following form:

Enter 
(Spanish form)

 

Your presentation must fulfill the following requirements:

    • Submit a “.doc” or “.docx” file with the description of the case to be presented. The text must be up to 300 words long, in an 11 pt font.

 

    • Submit a supplementary “.ppt” or “.pptx” file with the case presentation. While videos (up to 5) will be admitted for use during the oral presentation, this initial file can only include up to 5 fixed images.

 

    • Case and description must be submitted in english.
  •  
    • Presenters can submit more than one case. In such a circumstance, they shall make different submissions, one for each presentation.
 

Submission deadline: March 30th, 2018.

 

C3 is a Congress designed for physicians who specialize in interventional cardiology, vascular surgery, and interventional radiology, as well as fellows, residents, and other healthcare professionals interested in atherosclerotic cardiovascular disease. C3 offers presentations and debates with expert global faculty, live and pre-recorded cases, industry-sponsored and supported symposia, exhibit booths and simulators, poster sessions, case presentations and hands-on workshops.

 

Learn more www.c3conference.net


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

 

More articles by this author

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

Fellow’s Corner – Case 2: Acute Myocardial Infarction Due to Simultaneous Occlusion of Two Coronary Arteries

Share your experience. Learn from experts. Grow as an interventional cardiologist. A new edition of the Fellow’s Corner is here, an academic exchange space designed...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

V International Course on Cardiovascular Interventionism – SOLACI Scientific Endorsement

The Latin American Society of Interventional Cardiology (SOLACI) proudly grants its scientific endorsement to the V International Course on Cardiovascular Interventionism, an important academic...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...